Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021

SELL
$1.98 - $5.36 $1.03 Million - $2.8 Million
-522,360 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$1.05 - $2.77 $60,942 - $160,770
-58,040 Reduced 10.0%
522,360 $1.11 Million
Q3 2017

Nov 14, 2017

BUY
$0.94 - $1.35 $545,576 - $783,540
580,400
580,400 $772,000

Others Institutions Holding INFI

About INFINITY PHARMACEUTICALS, INC.


  • Ticker INFI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 89,277,904
  • Description
  • Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...
More about INFI
Track This Portfolio

Track Baker Bros. Advisors LP Portfolio

Follow Baker Bros. Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baker Bros. Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Baker Bros. Advisors LP with notifications on news.